For research teamsHelp me find a study
Back to all studies
CompletedNCT02428088

Dasotraline for ADHD

This study is completed in the United States. It is testing dasotraline for ADHD.

ADHDDrugFrom 6 Years to 12 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

Need help deciding?

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02428088. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

Check the official registry

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 43 sites
  • Harmonex Neuroscience Research
    Dothan, Alabama
    Site status: Not listed — confirm with the team
  • Synergy Research
    National City, California
    Site status: Not listed — confirm with the team
  • California Clinical Trials
    Paramount, California
    Site status: Not listed — confirm with the team
  • PCSD-Feighner Research
    San Diego, California
    Site status: Not listed — confirm with the team
  • Elite Clinical Trials, Inc.
    Wildomar, California
    Site status: Not listed — confirm with the team
  • MCB Clinical Research Centers, LLC
    Colorado Springs, Colorado
    Site status: Not listed — confirm with the team
  • Gulfcoast Clinical Research
    Fort Myers, Florida
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Trials - Parent
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Palm Springs Research Institute
    Hialeah, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions, Inc.
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center, LLC
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • iResearch Atlanta, LLC
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Capstone Clinical Research, Inc.
    Libertyville, Illinois
    Site status: Not listed — confirm with the team
  • Baber Research Group
    Naperville, Illinois
    Site status: Not listed — confirm with the team
  • Goldpoint Clinical Research
    Indianapolis, Indiana
    Site status: Not listed — confirm with the team
  • Pedia Research,LLC
    Newburgh, Indiana
    Site status: Not listed — confirm with the team
  • Psychiatric Associates
    Overland Park, Kansas
    Site status: Not listed — confirm with the team
  • Pedia Research,LLC
    Owensboro, Kentucky
    Site status: Not listed — confirm with the team
  • Hugo W. Moser Research Institute at Kennedy Krieger
    Baltimore, Maryland
    Site status: Not listed — confirm with the team
  • Massachusetts General Hospital
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Neurobehaviorial Medicine Group, PLLC
    Bloomfield Hills, Michigan
    Site status: Not listed — confirm with the team
  • Rochester Center for Behavioral Medicine
    Rochester Hills, Michigan
    Site status: Not listed — confirm with the team
  • Midwest Research Group
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Center for Psychiatry and Behavioral Medicine, Inc.
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Pharmaceutical Research Associates, Inc.
    Marlton, New Jersey
    Site status: Not listed — confirm with the team
  • Richmond Behavioral Associates
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Duke University Medical Center - Duke Child and Family Study Center
    Durham, North Carolina
    Site status: Not listed — confirm with the team
  • University of Cincinnati/Department of Psychiatry and Behavioral Neuroscience
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • University Hospitals Cleveland Medical Center
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • North Star Medical Research, LLC
    Middleburg Heights, Ohio
    Site status: Not listed — confirm with the team
  • IPS Research Company
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Cutting Edge Research Group
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Cyn3rgy Research
    Gresham, Oregon
    Site status: Not listed — confirm with the team
  • BioBehavioral Research of Austin P.C.
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research, LLC
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Bayou City Research Corporation
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Houston Clinical Trials, LLC
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Clinical Trials of Texas, Inc.
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Road Runner Research
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Family Psychiatry of The Woodlands, P.A.
    The Woodlands, Texas
    Site status: Not listed — confirm with the team
  • Aspen Clinical Research
    Orem, Utah
    Site status: Not listed — confirm with the team
In plain English

Key information made simple

What is this study testing?

This study is testing whether Dasotraline Versus Placebo may be useful for children experiencing ADHD.

What would participation involve?

Participants may receive Dasotraline Versus Placebo, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for children with ADHD. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

What to expect

Your next step

Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateApril 2015
Recruitment status
Completed
Enrollment listed in the registry
330
Sponsor
Sumitomo Pharma America, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT02428088
Official title
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Official source
Official registry link

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02428088. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Dasotraline, Placebo Comparator. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with adhd; age range: From 6 Years to 12 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Sumitomo Pharma America, Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.